Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, June 6, 2012 (GLOBE NEWSWIRE) -- Alliqua, Inc. (OTCBB:ALQA) ("Alliqua" or the "Company"), an advanced biomedical products company focused on the development and manufacturing of proprietary...
-
NEW YORK, May 22, 2012 (GLOBE NEWSWIRE) -- Alliqua, Inc. (OTCBB:ALQA) ("Alliqua" or the "Company"), an advanced biomedical products company focused on the development and manufacturing of proprietary...
-
NEW YORK, May 17, 2012 (GLOBE NEWSWIRE) -- Alliqua, Inc. (OTCBB:ALQA) ("Alliqua" or the "Company") announced today that Jerome Zeldis, MD, PhD, has joined its Board of Directors. Dr. Zeldis, an...
-
NEW YORK, May 15, 2012 (GLOBE NEWSWIRE) -- Alliqua, Inc. (OTCBB:ALQA) ("Alliqua" or the "Company") announced the appointment of Kenneth Londoner to its Board of Directors and Michael Goldberg, M.D. to...
-
NEW YORK, April 2, 2012 (GLOBE NEWSWIRE) -- Alliqua, Inc. (OTCBB:ALQA) ("Alliqua" or the "Company") announced that entrepreneur Dr. Phillip Frost and other investors collectively purchased...
-
NEW YORK, Feb. 7, 2012 (GLOBE NEWSWIRE) -- Alliqua, Inc. (OTCBB:ALQA) (FWB:HL1) ("Alliqua"), an advanced biomedical products company focused on the development and manufacturing of proprietary drug...
-
PHN pain patch development continues on schedule Antimicrobial advanced wound healing line scheduled for launch in 2012 Achievement of 2012 goals will expand, transform...
-
NEW YORK, Oct. 4, 2011 (GLOBE NEWSWIRE) -- Alliqua, Inc. (OTCBB:ALQA) (FWB:HL1) ("Alliqua" or the "Company"), an advanced biomedical products company focused on the development and manufacturing of...
-
NEW YORK, July 20, 2011 (GLOBE NEWSWIRE) -- Alliqua, Inc. (OTCBB:ALQA) (Frankfurt:HL1) ("Alliqua" or the "Company"). This press release corrects language throughout the press release that was issued...
-
NEW YORK, July 20, 2011 (GLOBE NEWSWIRE) -- Alliqua, Inc. (OTCBB:ALQA) (Frankfurt:HL1) ("Alliqua" or the "Company"), an advanced biomedical products company focused on the development and...